The role of SIRT3 inducers in preventing alveolar epithelial cell death and lung fibrosis
SIRT3诱导剂在预防肺泡上皮细胞死亡和肺纤维化中的作用
基本信息
- 批准号:9379398
- 负责人:
- 金额:$ 3.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2018-02-28
- 项目状态:已结题
- 来源:
- 关键词:8-Oxoguanine DNA GlycosylaseAcetylationAconitate HydrataseAgingAlveolarAntioxidantsApoptosisAsbestosAsbestosisAttenuatedBiological PreservationBleomycinBreast Epithelial CellsCell DeathCellsCessation of lifeChromatin StructureCitric Acid CycleComplexDNA DamageDNA RepairDataDeacetylaseDevelopmentDiseaseDisease ProgressionElectron TransportEnergy MetabolismEpithelialEpithelial CellsEpitheliumEquilibriumEventExposure toFDA approvedFamilyFibrosisGenomeGenome StabilityHamman-Rich syndromeHistone DeacetylationHumanHydrogen PeroxideIn VitroInjuryInvestigationLeadLungLung diseasesMaintenanceMediatingMesenchymalMetabolicMitochondriaMitochondrial DNAMitochondrial ProteinsMusNatureOGG1 geneOxidantsOxidative StressPathogenesisPathway interactionsPatientsPlayPreparationPreventionProductionProtein AcetylationPulmonary FibrosisReportingRespiratory physiologyResveratrolRoleSOD2 geneSirtuinsSmall Interfering RNATNF geneTP53 geneTestingTherapeuticTransforming Growth Factor betaTranslatingage relatedalveolar epitheliumalveolar type II cellanti agingantioxidant enzymecoronary fibrosisexperiencehonokiolin vivoinsightlung injurymembermitochondrial dysfunctionmitochondrial genomenovelnovel therapeuticspreventprotective effectprotein expressionsmall molecule
项目摘要
Project Summary/Abstract
The pathogenesis of age-related idiopathic pulmonary fibrosis (IPF) and asbestosis is complex and
incompletely understood, though accumulating evidence firmly implicates mitochondrial DNA (mtDNA) damage
that lead to alveolar epithelial cell (AEC) apoptosis as a key event in disease development. We previously
showed that the extent of AEC mtDNA damage, mitochondrial aconitase (ACO-2) depletion and apoptosis are
critical determinants of the fibrogenic potential of asbestos. Sirtuin 3 (SIRT3) is the major mitochondrial
deacetylase and considered the “guardian of the mitochondrial genome” through its role in regulating
mitochondrial proteins that detoxify oxidative stress and preserve mtDNA via modulation of mitochondrial 8-
oxoguanine DNA glycosylase (OGG1) and ACO-2 activities. Our preliminary studies in preparation for this
proposal show that oxidative stress (asbestos or H2O2) decreases AEC SIRT3 protein expression; that SIRT3
silencing augments while SIRT3 enforced expression (EE) attenuates oxidant-induced AEC ACO-2 depletion,
mtDNA damage, and apoptosis; that SIRT3 deficiency enhances asbestos- and bleomycin-induced pulmonary
fibrosis in association with increased AEC mtDNA damage; and that lungs from patients with idiopathic
pulmonary fibrosis (IPF) have increased acetylation of OGG1 and MnSOD. Taken together, these data
suggest a novel role for SIRT3 in the maintenance of a healthy alveolar epithelium and prevention of fibrotic
lung diseases. We hypothesize that honokiol, a small molecule SIRT3 inducer, attenuates oxidant-induced
AEC mtDNA damage, mitochondrial ROS production, and apoptosis as well as pulmonary fibrosis in part by
maintaining expression and activity of OGG1, ACO-2, and MnSOD. We have formulated two related aims to
test this hypothesis. In Aim 1, we will determine whether honokiol prevents oxidant-induced AEC mtDNA
damage and intrinsic apoptosis in vitro via a SIRT3-dependent mechanism involving preservation of AEC
mitochondrial protein (OGG1, ACO-2, MnSOD) function and reduction in protein acetylation and mitochondrial
ROS. In Aim 2, we will use wild-type and Sirt3-/- mice to determine whether honokiol and resveratrol (another
small molecule sirtuin inducer) mitigate pulmonary fibrosis (asbestos or bleomycin) in vivo by a SIRT3-
dependent mechanism and whether protection is associated with reductions in alveolar epithelial type 2 cell
(AT2) OGG1 and MnSOD acetylation, mtDNA damage, and apoptosis. These studies will elucidate the
importance of honokiol-induced SIRT3-EE in preserving AT2 cell mtDNA integrity and preventing lung fibrosis
which may have broad implications for the treatment of IPF and other fibrotic lung diseases.
项目概要/摘要
与年龄相关的特发性肺纤维化(IPF)和石棉肺的发病机制很复杂,
尚未完全了解,但越来越多的证据明确表明线粒体 DNA (mtDNA) 损伤
导致肺泡上皮细胞(AEC)凋亡是疾病发展的关键事件。
结果表明,AEC mtDNA 损伤、线粒体顺乌头酸酶 (ACO-2) 耗竭和细胞凋亡的程度
Sirtuin 3 (SIRT3) 是石棉纤维化潜力的关键决定因素。
脱乙酰酶并通过其在调节中的作用被认为是“线粒体基因组的守护者”
线粒体蛋白通过调节线粒体 8- 解毒氧化应激并保护 mtDNA
我们为此做准备的初步研究。
提案表明氧化应激(石棉或 H2O2)会降低 AEC SIRT3 蛋白的表达;
沉默增强而 SIRT3 强制表达 (EE) 减弱氧化剂诱导的 AEC ACO-2 耗竭,
mtDNA 损伤和细胞凋亡;SIRT3 缺乏会增强石棉和博来霉素诱导的肺损伤
纤维化与 AEC mtDNA 损伤增加有关;特发性患者的肺部
肺纤维化 (IPF) 增加了 OGG1 和 MnSOD 的乙酰化程度。
表明 SIRT3 在维持健康肺泡上皮和预防纤维化方面具有新作用
我们相信和厚朴酚是一种小分子 SIRT3 诱导剂,可以减轻氧化剂诱导的肺部疾病。
AEC mtDNA 损伤、线粒体 ROS 产生、细胞凋亡以及肺纤维化部分由
维持 OGG1、ACO-2 和 MnSOD 的表达和活性我们制定了两个相关目标。
在目标 1 中,我们将确定诺木酚是否可以预防氧化剂诱导的 AEC mtDNA。
通过 SIRT3 依赖性机制(涉及 AEC 的保存)进行体外损伤和内在凋亡
线粒体蛋白(OGG1、ACO-2、MnSOD)功能以及蛋白质乙酰化和线粒体的减少
在目标 2 中,我们将使用野生型和 Sirt3-/- 小鼠来确定和厚朴酚和白藜芦醇(另一种
小分子 Sirtuin 诱导剂)通过 SIRT3- 减轻体内肺纤维化(石棉或博莱霉素)
依赖机制以及保护是否与肺泡上皮 2 型细胞减少相关
(AT2) OGG1 和 MnSOD 乙酰化、mtDNA 损伤和细胞凋亡。
和厚朴酚诱导的 SIRT3-EE 在保护 AT2 细胞 mtDNA 完整性和预防肺纤维化中的重要性
这可能对 IPF 和其他纤维化肺部疾病的治疗具有广泛的影响。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Renea Poppino Jablonski其他文献
Renea Poppino Jablonski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
高糖水平通过JUN乙酰化修饰上调NCAPD3促进结直肠癌发生的分子机制
- 批准号:82303250
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
β-羟基丁酸介导NF-kB p65去乙酰化修饰在经腹功能性磁刺激治疗脊髓损伤后神经病理性疼痛中的机制研究
- 批准号:82302862
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于ChREBP乙酰化介导脂肪酸代谢探讨“肝病及心”理论内涵及降脂消斑方干预研究
- 批准号:82374192
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
DEPDC5蛋白乙酰化修饰导致mTROC1的激活并促进骨肉瘤的恶性进展
- 批准号:82360472
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Mechanisms of metabolic stress-induced transcriptional regulation in prostate cancer
前列腺癌代谢应激诱导的转录调控机制
- 批准号:
10818087 - 财政年份:2023
- 资助金额:
$ 3.37万 - 项目类别:
Mechanisms of metabolic stress-induced transcriptional regulation in prostate cancer
前列腺癌代谢应激诱导的转录调控机制
- 批准号:
10590678 - 财政年份:2021
- 资助金额:
$ 3.37万 - 项目类别:
Mechanisms of metabolic stress-induced transcriptional regulation in prostate cancer
前列腺癌代谢应激诱导的转录调控机制
- 批准号:
10376802 - 财政年份:2021
- 资助金额:
$ 3.37万 - 项目类别:
Mechanisms of metabolic stress-induced transcriptional regulation in prostate cancer
前列腺癌代谢应激诱导的转录调控机制
- 批准号:
10209389 - 财政年份:2021
- 资助金额:
$ 3.37万 - 项目类别:
INVESTIGATING THE ROLE OF THE TRANSCRIPTIONAL COREGULATOR SRC-2 IN CASTRATION RESISTANT PROSTATE CANCER
研究转录核心调节子 SRC-2 在去势抵抗性前列腺癌中的作用
- 批准号:
9763341 - 财政年份:2017
- 资助金额:
$ 3.37万 - 项目类别: